Projekte pro Jahr
Abstract
Augmented Toll-like receptor 4 (TLR4) expression was found in nearly 70% of patients with pancreatic adenocarcinoma, which is correlated with increased tumorigenesis and progression. In this study, we engineered a new light-oxygen-voltage-sensing (LOV) domain-based optogenetic cell line (opto-TLR4 PANC-1) that enables time-resolved activation of the NF-κB and extracellular-signal regulated kinases (ERK)1/2 signalling pathway upon blue light-sensitive homodimerisation of the TLR4-LOV fusion protein. Continuous stimulation with light indicated strong p65 and ERK1/2 phosphorylation even after 24 h, whereas brief light exposure peaked at 8 h and reached the ground level 24 h post-illumination. The cell line further allows a voltage-dependent TLR4 activation, which can be continuously monitored, turned on by light or off in the dark. Using this cell line, we performed different phenotypic cell-based assays with 2D and 3D cultures, with the aim of controlling cellular activity with spatial and temporal precision. Light exposure enhanced cell attachment, the formation and extension of invadopodia, and cell migration in 3D spheroid cultures, but no significant changes in proliferation or viability could be detected. We conclude that the opto-TLR4 PANC-1 cell line is an ideal tool for investigating the underlying molecular mechanisms of TLR4, thereby providing strategies for new therapeutic options.
Originalsprache | Englisch |
---|---|
Aufsatznummer | 9232 |
Fachzeitschrift | International Journal of Molecular Sciences |
Jahrgang | 22 |
Ausgabenummer | 17 |
DOIs | |
Publikationsstatus | Veröffentlicht - 26 Aug. 2021 |
IMC Forschungsschwerpunkte
- Medical biotechnology
ÖFOS 2012 - Österreichischen Systematik der Wissenschaftszweige
- 304005 Medizinische Biotechnologie
Fingerprint
Untersuchen Sie die Forschungsthemen von „Light-inducible spatio-temporal control of tlr4 and nf-κb-gluc reporter in human pancreatic cell line“. Zusammen bilden sie einen einzigartigen Fingerprint.Projekte
- 1 Abgeschlossen
-
Entwicklung leistungsfähiger Diagnostikverfahren und neuer Therapieansätze in Inflammation und Sepsis
Wiesner, C. (Leitende(r) Forscher/-in), Grünstäudl, P. (Weitere Forschende), Colleselli, K. (Weitere Forschende) & Stierschneider, A. (Weitere Forschende)
18/09/19 → 24/01/24
Projekt: Forschung
Auszeichnungen
Presseberichte
-
Neues optogenetisches Forschungsprojekt in der Krebstherapie
Stierschneider, A. & Wiesner, C.
1/02/22
1 eigener Medienbeitrag
Presse/Medien